In patients who present with both cataract and Fuchs’ endothelial corneal dystrophy,
ophthalmologists have the option of performing cataract extraction alone or simultaneously with
Descemet’s stripping automated endothelial …
Author: ModernMedecine
Prevent Blindness America Swing Fore Sight Golf Tournament supports eye programs
Sight-saving programs of Prevent Blindness America (PBA) will be supported by the 5th Annual Swing
Fore Sight Golf Tournament, a four-person scramble set for Sept. 5 at the Royal Links Golf Club in Las
Vegas.
Femtosecond laser cleared by FDA
Bausch + Lomb (B + L) and Technolas Perfect Vision GmbH (TPV) have received 510(k) clearance from the
FDA for a femtosecond laser platform (Victus), and it is now available for shipment within the United
States.
Jason Woody honored by EBAA
Jason Woody, president and chief executive officer of the Lions Eye Institute for Transplant
& Research (LEITR), has received the Leonard Heise Award from the Eye Bank Association of America
(EBAA).
Haag-Streit, Reliance Medical Products name Ernest Cavin president, CEO
Ernest Cavin, MBA, DBA, has been named president and chief executive officer (CEO) of Haag-Streit USA
and Reliance Medical Products, both based in Mason, OH.
Bryan Lee, MD, JD, wins Vanguard Ophthalmology Society Scholar Award
Bryan S. Lee, MD, JD, a cornea, glaucoma, and refractive surgery fellow at Minnesota Eye Consultants,
is the inaugural recipient of the Vanguard Ophthalmology Society Scholar Award.
Combined or separate cataract, DSAEK procedures in Fuchs’ dystrophy?Fuchs’ dystrophy: When to operate?
In patients who present with both cataract and Fuchs’ endothelial corneal dystrophy,
ophthalmologists have the option of performing cataract extraction alone or simultaneously with
Descemet’s stripping automated endothelial …
Sightpath expands social media efforts
Sightpath, a provider of mobile and fixed ophthalmic surgical products, has created a company blog, a
Facebook page, a Twitter account, and a Vimeo channel, as well as a fortified LinkedIn profile.
Cataract surgery reduces hip fracture risk
Patients who had cataract removal surgery were found to have a 16% decrease in the risk of hip
fracture compared with patients who did not undergo the procedure, according to an observational study of more than
400,000 Medicare beneficiaries.
Race-based hemoglobin A1C diagnostic cutoff points unwarranted: study
NEW YORK (Reuters Health) – Results of a new study do not support increasing the diagnostic threshold
of hemoglobin A1C in blacks, say researchers from Beth Israel Deaconess Medical Center, Boston, in a report
published today.
Protein may block diabetic retinopathy damage
A protein that could “interrupt” the chain of events that causes retinal
damage in diabetic retinopathy has been identified by researchers at the University of Michigan Kellogg Eye Center.
The finding could lead to a therapy…
Glaucoma imaging takes its place in clinical practice
Use of imaging in clinical practice offers clinicians a number of advantages for following patients
with glaucoma, perhaps most importantly the ability sometimes to detect damage before it is apparent on fundus
photographs, objective rates of g…
Fewer hip fractures after cataract surgery
NEW YORK (Reuters Health) – In a new study, older adults who had cataract surgery were less likely to
fracture a hip in the next year compared to those with cataracts who didn’t get surgery.
No benefit to bevacizumab in advanced AMD
NEW YORK (Reuters Health) – Intravitreal bevacizumab does not benefit patients with advanced
neovascular age-related macular degeneration (AMD) and very poor vision, according to a new 21-patient
study.
FDA panel endorses drug for vitreomacular adhesion
WASHINGTON (Reuters) – A Food and Drug Administration panel on Thursday recommended ThromboGenics NV’s
ocriplasmin as a treatment for vitreomacular adhesion, an aging-related vision problem that can lead to
blindness.
FDA panel gives nod to drug for diabetic macular edema
FDA staff say Lucentis eases diabetic macular edema
WASHINGTON (Reuters) – U.S. drug reviewers on Tuesday said Roche Holding AG’s drug Lucentis appeared
to help patients with diabetic macular edema (DME).
UK authority backs down in Novartis eye drug dispute
LONDON (Reuters) – A regional British health authority said on Wednesday it had decided to stop using
the cancer drug Avastin as a cheap alternative to eye medicine Lucentis following a legal challenge from Novartis,
which sells Lucentis in Eur…
US FDA staff questions dosing of Lucentis eye drug
WASHINGTON (Reuters) – U.S. drug reviewers on Tuesday said Roche Holding AG’s eye drug Lucentis
(ranibizumab injection) appeared to help patients with diabetic macular edema (DME), but questioned whether two
different doses of the drug were equ…